PURPOSE: To investigate the effects of caffeine (CAF) on performance during high- and long-jump competitions. METHODS: Using a crossover and double-blind design, 6 well-trained high jumpers and 6 well-trained long jumpers performed a simulation of a high- and long-jump competition 60 minutes after ingesting a capsule containing either 5 mg·kg-1 body mass of anhydrous CAF or a placebo. The high jumps were video recorded for kinematic analysis. The velocity during the approach run of the long jump was also monitored using photocells. RESULTS: CAF improved jump performance (ie, the highest bar height overlap increased by 5.1% [2.3%], P = .008), as well as enhancing the height displacement of the central body mass (+1.3% [1.7%], P = .004) compared with the placebo. CAF had no ergogenic effect on jump distance (P = .722); however, CAF increased the velocity during the last 10 m of the long jump (P = .019), and the percentage of "foul jumps" was higher than that expected by chance in the CAF group (80.5% [12.5%], χ2 = 13.44, P < .001) but not in the cellulose condition (58.3% [22.9%], χ2 = 1.48, P = .224). CONCLUSION: CAF ingestion (5 mg·kg-1 body mass) improves high-jump performance but seems to negatively influence technical aspects during the approach run of the long jump, resulting in no improvement in long-jump performance. Thus, CAF can be useful for jumpers, but the specificity of the jump competition must be taken into account.
PURPOSE: To investigate the effects of caffeine (CAF) on performance during high- and long-jump competitions. METHODS: Using a crossover and double-blind design, 6 well-trained high jumpers and 6 well-trained long jumpers performed a simulation of a high- and long-jump competition 60 minutes after ingesting a capsule containing either 5 mg·kg-1 body mass of anhydrous CAF or a placebo. The high jumps were video recorded for kinematic analysis. The velocity during the approach run of the long jump was also monitored using photocells. RESULTS: CAF improved jump performance (ie, the highest bar height overlap increased by 5.1% [2.3%], P = .008), as well as enhancing the height displacement of the central body mass (+1.3% [1.7%], P = .004) compared with the placebo. CAF had no ergogenic effect on jump distance (P = .722); however, CAF increased the velocity during the last 10 m of the long jump (P = .019), and the percentage of "foul jumps" was higher than that expected by chance in the CAF group (80.5% [12.5%], χ2 = 13.44, P < .001) but not in the cellulose condition (58.3% [22.9%], χ2 = 1.48, P = .224). CONCLUSION: CAF ingestion (5 mg·kg-1 body mass) improves high-jump performance but seems to negatively influence technical aspects during the approach run of the long jump, resulting in no improvement in long-jump performance. Thus, CAF can be useful for jumpers, but the specificity of the jump competition must be taken into account.
Authors: Fabiano Tomazini; Ana Carla Santos-Mariano; Vinicius F Dos S Andrade; Daniel B Coelho; Romulo Bertuzzi; Gleber Pereira; Marcos D Silva-Cavalcante; Adriano E Lima-Silva Journal: Eur J Appl Physiol Date: 2022-05-25 Impact factor: 3.346
Authors: Verónica Giráldez-Costas; Millán Aguilar-Navarro; Jaime González-García; Juan Del Coso; Juan José Salinero Journal: J Int Soc Sports Nutr Date: 2022-07-06 Impact factor: 4.948